Substrate utilization and glycolysis in the heart.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000693:Anaerobiosis; D000818:Animals; D002395:Catecholamines / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000037:antagonists & inhibitors / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis; D006321:Heart / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000378:metabolism; D007328:Insulin / Q000502:physiology; D007657:Ketone Bodies / Q000378:metabolism; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D009203:Myocardial Infarction / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009249:NADP / Q000494:pharmacology; D010101:Oxygen Consumption
D000227:Adenine Nucleotides; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007657:Ketone Bodies; D007773:Lactates; D009249:NADP; D000255:Adenosine Triphosphate; D006003:Glycogen; D005947:Glucose